KRISTI CAPALDI: Open Payments
NPI 1780999185 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,730 in 96 payments from 16 companies in 2025. Trend: 2023 $692 · 2024 $1,432 · 2025 $1,730
Food & beverage: $1,730
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $394 |
| ABBVIE INC. | 13 | $221 |
| Orexo US, Inc. | 11 | $201 |
| AstraZeneca Pharmaceuticals LP | 9 | $173 |
| Otsuka America Pharmaceutical, Inc. | 7 | $152 |
| Teva Pharmaceuticals USA, Inc. | 7 | $124 |
| Lundbeck LLC | 5 | $98 |
| Gilead Sciences, Inc. | 3 | $80 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Exact Sciences Corporation | 3 | $61 |
Products named: CAPLYTA, REXULTI, Zubsolv, AUSTEDO XR, VRAYLAR, FARXIGA, INGREZZA, AIRSUPRA.
Industry payments across MI — which companies pay providers there.
